Structure and function analysis of Sam68 and hnRNP A1 synergy in the exclusion of exon 7 from SMN2 transcripts
Protein Science · 2023
DOI: 10.1002/pro.4553 ↗At a glance
Journal article in Protein Science, 2023. Written by Marta Nadal and 5 co-authors. Institution: Molecular Bases of Disease, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain. Major MEDLINE topics: Neurodegenerative Diseases, Muscular Atrophy, Spinal. Cited 4 times so far (Crossref); 69 references. The full text is freely available in PubMed Central. Funded by: The Daniel Bravo Andreu Private Foundation, Ministry of Science and Innovation, Spinal Muscular Atrophy Foundation.
Abstract (original language)
Spinal muscular atrophy (SMA) is a neurodegenerative disease caused by the absence of a functional copy of the Survival of Motor Neuron 1 gene ( SMN1 ). The nearly identical paralog, SMN2 , cannot compensate for the loss of SMN1 because exon 7 is aberrantly skipped from most SMN2 transcripts, a process mediated by synergistic activities of Src‐associated during mitosis, 68 kDa (Sam68/KHDRBS1) and heterogeneous nuclear ribonucleoprotein (hnRNP) A1. This results in the production of a truncated, nonfunctional protein that is rapidly degraded. Here, we present several crystal structures of Sam68 RNA‐binding domain (RBD). Sam68‐RBD forms stable symmetric homodimers by antiparallel association of helices α3 from two monomers. However, the details of domain organization and the dimerization interface differ significantly from previously characterized homologs. We demonstrate that Sam68 and hnRNP A1 can simultaneously bind proximal motifs within the central region of SMN2 (ex7). Furthermore, we show that the RNA‐binding pockets of the two proteins are close to each other in their heterodimeric complex and identify contact residues using crosslinking‐mass spectrometry. We present a model of the ternary Sam68· SMN2 (ex7)·hnRNP A1 complex that reconciles all available information on SMN1 / 2 splicing. Our findings have important implications for the etiology of SMA and open new avenues for the design of novel therapeutics to treat splicing diseases.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Molecular Bases of Disease, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.
- Structural Biology of Nuclear Receptors, Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, Institute of Biomedicine (IBUB) of the University of Barcelona (UB), Barcelona, Spain.
- Medicine Genetics Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.
- Department of Clinical and Molecular Genetics, Hospital Vall d'Hebron, Barcelona, Spain.
ORCID profiles: Eva Estébanez-Perpiñá, Pablo Fuentes-Prior
Funding
- The Daniel Bravo Andreu Private Foundation
- Ministry of Science and Innovation
- Spinal Muscular Atrophy Foundation
Cite
APA
Nadal, M., Anton, R., Dorca-Arévalo, J., Estébanez-Perpiñá, E., Tizzano, E. F., & Fuentes-Prior, P. (2023). Structure and function analysis of Sam68 and hnRNP A1 synergy in the exclusion of exon 7 from SMN2 transcripts. Protein Science. https://doi.org/10.1002/pro.4553
Vancouver
Nadal M, Anton R, Dorca-Arévalo J, Estébanez-Perpiñá E, Tizzano EF, Fuentes-Prior P. Structure and function analysis of Sam68 and hnRNP A1 synergy in the exclusion of exon 7 from SMN2 transcripts. Protein Science. 2023. doi:10.1002/pro.4553
BibTeX
@article{Nadal2023,
author = {Nadal, Marta and Anton, Rosa and Dorca-Arévalo, Jonatan and Estébanez-Perpiñá, Eva and Tizzano, Eduardo F and Fuentes-Prior, Pablo},
title = {Structure and function analysis of Sam68 and hnRNP A1 synergy in the exclusion of exon 7 from SMN2 transcripts},
journal = {Protein Science},
year = {2023},
doi = {10.1002/pro.4553}
}
EUVIMED